FutureMED Ventures KZ, the first Kazakh-American venture fund for innovative medical technologies, has been launched in the US state of Delaware, the-tech.kz online publication reports.
The FutureMED Ventures KZ team consists of well-known American and Kazakh experts in the commercialization of scientific developments in the field of biomedicine and medical products. The fund is engaged in the search and selection of companies developing promising innovative technologies in the field of medicine, and then financing clinical trials of these technologies in exchange for company shares.
If the clinical trial is successfully completed, the value of the company may increase by 10 times, depending on the market size and the level of demonstratThe total planned value of the fund is $400 million.ed effectiveness.
The management of the fund has developed a unique idea of transformation in the field of research, conducting clinical experiments in medical institutions in Kazakhstan.
The unique strategy of the FutureMED Ventures KZ fund is aimed at developing the market for clinical experiences.
Source: the-tech.kz website